Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma
โ Scribed by Robert R. McWilliams; Gloria M. Petersen; Kari G. Rabe; Leonard M. Holtegaard; Pamela J. Lynch; Michele D. Bishop; W. Edward Highsmith Jr
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 146 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Review: 79 refs.
The mutation described here has been detected in the DNA of a female cystic fibrosis (CF) patient born in May 1963. CF has been diagnosed only at the age of 30 years and has been confirmed by three positive sweat tests. She does not require supplementation with pancreatic enzymes and her pulmonary f
A novel nonsense mutation, S434X,
## For the Mutation Pathogenicity Special Issue We have been investigating the functional consequences of rare disease-associated amino acid substitutions in the cystic fibrosis transmembrane conductance regulator (CFTR). Mutations of the arginine residue at codon 1070 have been associated with di